Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ·Healthcare·Biotechnology
$283.63
-0.38%
Mkt Cap $5.70B
Analyst Ratings
Buy
12
Hold
0
Sell
0
Price Target (20 analysts)
$291.00
Range $252.00 – $332.00
Implied Upside
+2.6%
Consensus $291.00 vs current $283.63